| Name | Lenswear Inc |
|---|---|
| Organization Name | Lenswear Inc |
| Location | 186 Boulevard, Hasbrouck Heights, New Jersey 07604 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (201) 393-9717 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
As a nation we spend nearly $7,300 per person on health care each year - but are we getting the best possible value for our dollars? Exploring promising innovative approaches to getting high quality from health care purchases while ensuring that our annual $2.3 trillion in public and private health care spending is going as far as it should - in terms of top quality care, improved health outcomes and minimal waste - will be part of new work undertaken by the Engelberg Center for Health Care Reform at Brookings and supported by the Aetna Foundation.
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of a new drug to treat hypertension.
As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.
› Verified 6 days ago
| NPI Number | 1376719278 |
| Organization Name | LENSWEAR, INC |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 186 Boulevard, Hasbrouck Heights, NJ 07604 |
| Phone Number | 201-393-9717 |
News Archive
As a nation we spend nearly $7,300 per person on health care each year - but are we getting the best possible value for our dollars? Exploring promising innovative approaches to getting high quality from health care purchases while ensuring that our annual $2.3 trillion in public and private health care spending is going as far as it should - in terms of top quality care, improved health outcomes and minimal waste - will be part of new work undertaken by the Engelberg Center for Health Care Reform at Brookings and supported by the Aetna Foundation.
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of a new drug to treat hypertension.
As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.
› Verified 6 days ago
News Archive
As a nation we spend nearly $7,300 per person on health care each year - but are we getting the best possible value for our dollars? Exploring promising innovative approaches to getting high quality from health care purchases while ensuring that our annual $2.3 trillion in public and private health care spending is going as far as it should - in terms of top quality care, improved health outcomes and minimal waste - will be part of new work undertaken by the Engelberg Center for Health Care Reform at Brookings and supported by the Aetna Foundation.
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of a new drug to treat hypertension.
As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.
› Verified 6 days ago
Heights Specialty Pharmacy Type: Pharmacy Location: 450 Boulevard, Hasbrouck Heights, New Jersey 07604 Phone: (201) 288-0404 | |
Lenswear Inc Type: Eyewear Supplier (Equipment, not the service) Location: 186 Boulevard, Hasbrouck Heights, New Jersey 07604 Phone: (201) 393-9717 | |
Walgreen Co Type: Durable Medical Equipment & Medical Supplies Supplier Location: 151 Boulevard, Hasbrouck Heights, New Jersey 07604 Phone: (201) 288-5500 |